Advertisement

Topics

CannaRoyalty CEO Marc Lustig to Present at Canaccord Genuity Growth Conference in Boston

20:00 EDT 6 Aug 2017 | Marketwired

OTTAWA, ONTARIO -- (Marketwired) -- 08/07/17 -- CannaRoyalty Corp. (CSE: CRZ)(CSE: CRZ.CN)(CNSX: CRZ)(OTCQX: CNNRF) ("CannaRoyalty" or the "Company"), a fully integrated, active investor and operator in the legal cannabis industry, will be participating in the 37th Annual Canaccord Genuity Growth Conference. The conference will be held at the InterContinental Waterfront Promenade in Boston. Marc Lustig, Chief Executive Officer, will be presenting on Wednesday, August 9, 2017 at 12:00 p.m. (ET) in the Hong Kong Room.

The webcast can be accessed on the day of the conference through the following link:

http://bit.ly/2vxmrnG

This link will be available for 363 days following the conference.

The presentation and link to the webcast will also be available on cannaroyalty.com in the Investor Relations section.

About CannaRoyalty

CannaRoyalty is a fully integrated, active investor and operator in the legal cannabis sector. Our focus is building and supporting a diversified portfolio of growth-ready assets in high-value segments of the cannabis sector, including research, consumer brands, devices and intellectual property. Our management team combines a hands-on understanding of the cannabis industry with seasoned financial know-how, assembling a platform of holdings via royalty agreements, equity interests, secured convertible debt, licensing agreements and its own branded portfolio.

Contacts: CannaRoyalty Corp. Investor Relations 1-844-556-5070 LodeRock Advisors Inc. Jonathan Ross, CFA 416-283-0178 NEXT ARTICLE

More From BioPortfolio on "CannaRoyalty CEO Marc Lustig to Present at Canaccord Genuity Growth Conference in Boston "

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...